BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2021 8:56:50 AM | Browse: 342 | Download: 674
 |
Received |
|
2020-09-20 15:01 |
|
Peer-Review Started |
|
2020-09-20 15:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-10-21 15:11 |
|
Revised |
|
2020-12-30 11:58 |
|
Second Decision |
|
2021-01-25 07:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-01-26 03:29 |
|
Articles in Press |
|
2021-01-26 03:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-01-30 22:38 |
|
Typeset the Manuscript |
|
2021-03-16 10:40 |
|
Publish the Manuscript Online |
|
2021-03-30 08:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by Perbrolizumab: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiao-He Yu, Jian Huang, Nai-Jian Ge, Ye-Fa Yang and Jin-Yan Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
31971249 |
|
| Corresponding Author |
Jin-Yan Zhao, MD, Attending Doctor, Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 85 Wujin Road, Shanghai 200080, China. jingy1213@163.com |
| Key Words |
Undifferentiated embryonal sarcoma of the liver; Perbrolizumab; Programmed cell death protein 1; Tumor mutation burden; Immunohistology; Case report |
| Core Tip |
Undifferentiated embryonal sarcoma of the liver is unusual neoplasms, which was mainly treated by resection and adjuvant multiagent chemotherapy. Immunotherapy, such as antibody of programmed cell death protein 1 (anti-PD-1) has not been reported to be used to treat this disease. Here we reported a recurrent UESL case in an adult which treated by Perbrolizumab and discuss the way to find the proper candidates for anti-PD-1 treatment. |
| Publish Date |
2021-03-30 08:56 |
| Citation |
Yu XH, Huang J, Ge NJ, Yang YF, Zhao JY. Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by Perbrolizumab: A case report. World J Clin Cases 2021; 9(10): 2281-2288 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i10/2281.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i10.2281 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
